XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Total revenues $ 1,537 $ 1,298 $ 3,829 $ 3,677
Operating expenses :        
Cost of revenues 1,032 818 2,136 1,996
Research and development 24 15 40 55
Gain on sale of intangible assets 0 0 (4,000) 0
Impairment of property and equipment 0 0 36 0
Selling, general and administrative 2,241 1,862 6,986 6,535
Total operating expenses 3,297 2,695 5,198 8,586
Loss from continuing operations (1,760) (1,397) (1,369) (4,909)
Interest income 233 133 428 538
Other income , net 15 17 168 36
Valuation loss on March 2023 PIPE 0 0 0 (6,076)
Change in fair value of common stock warrant and option liabilities 330 608 493 5,965
Issuance and offering costs allocated to liability classified options 0 0 0 (430)
Net loss from continuing operations before income taxes (1,182) (639) (280) (4,876)
Income tax provision 0 0 0 (1)
Net loss from continuing operations (1,182) (639) (280) (4,877)
Net loss (1,612) (2,567) (2,974) (11,133)
Net loss attributable to non-controlling interest 0 0 0 (5)
Net loss attributable to common stockholders $ (1,612) $ (2,567) $ (2,974) $ (11,128)
Net loss per share attributable to common stockholders:        
Basic net loss per share attributable to common stockholders from continuing operations $ (0.87) $ (0.47) $ (0.21) $ (4.08)
Diluted net loss per share attributable to common stockholders from continuing operations (0.87) (0.47) (0.21) (4.08)
Basic net loss per share attributable to common stockholders from discontinued operations (0.32) (1.42) (1.98) (5.24)
Net loss per basic share attributable to common stockholders (1.18) (1.89) (2.18) (9.31)
Net loss per diluted share attributable to common stockholders $ (1.18) $ (1.89) $ (2.18) $ (9.31)
Weighted-average number of shares used in per share calculations:        
Weighted average shares - Basic 1,363,753 1,359,511 1,362,754 1,195,354
Weighted average shares - Diluted 1,363,753 1,359,511 1,362,754 1,195,354
Other comprehensive income (loss), net of tax        
Unrealized gains on available-for-sale securities $ 36 $ 66 $ 117 $ 87
Reclassification adjustment for gains on available-for-sale securities included in net loss 0 0 (111) 0
Change in unrealized gains on available-for-sale securities 36 66 6 87
Comprehensive loss (1,576) (2,501) (2,968) (11,041)
Body Care        
Operating expenses :        
Net loss from discontinued operations 0 (83) 0 (591)
GoodWheat        
Operating expenses :        
Net loss from discontinued operations (430) (1,845) (2,694) (5,665)
Product        
Revenues:        
Total revenues 1,537 1,298 3,829 3,667
License        
Revenues:        
Total revenues $ 0 $ 0 $ 0 $ 10